Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The following table summarizes information about stock option activity for the year to date period ended September 30, 2023:

	Shares			Weighted Average Exercise Price
Outstanding at January 1, 2023	287,444			$	28.56
Granted	57,680			31.47
Exercised	(3,885)			20.95
Forfeited	(35,139)			30.91
Outstanding at September 30, 2023	306,100			28.94
Vested at Period-End	207,642			27.81
Expected to Vest	98,458			31.32
Stock Options Granted
Weighted Average Grant Date Information:
Fair Value of Options Granted	$	7.78
Fair Value Assumptions:
Dividend Yield	3.30		%
Expected Volatility	28.38		%
Risk Free Interest Rate	3.57		%
Expected Lives (in years)	8.34

Schedule of Stock Options Roll Forward

The following table summarizes information about stock option activity for the year to date period ended September 30, 2023:

	Shares			Weighted Average Exercise Price
Outstanding at January 1, 2023	287,444			$	28.56
Granted	57,680			31.47
Exercised	(3,885)			20.95
Forfeited	(35,139)			30.91
Outstanding at September 30, 2023	306,100			28.94
Vested at Period-End	207,642			27.81
Expected to Vest	98,458			31.32
Stock Options Granted
Weighted Average Grant Date Information:
Fair Value of Options Granted	$	7.78
Fair Value Assumptions:
Dividend Yield	3.30		%
Expected Volatility	28.38		%
Risk Free Interest Rate	3.57		%
Expected Lives (in years)	8.34

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs

The following table presents information on the amounts expensed related to stock options for the three and nine month periods ended September 30, 2023 and 2022:

	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2023		2022		2023		2022
Amount expensed	$	24	$	79	$	196	$	233

The following table presents information on the amounts expensed related to restricted stock units for the periods ended September 30, 2023 and 2022:

	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2023		2022		2023		2022
Amount expensed	$	246	$	35	$	321	$	105

Schedule of Nonvested Restricted Stock Units Activity

The following table summarizes information about restricted stock unit activity for the periods ended September 30, 2023 and 2022:

	Restricted Stock Units	Weighted Average Grant Date Fair Value
Non-vested at January 1, 2023	13,925	$	30.47
Granted	5,164	31.47
Vested	(19,089)	30.74
Non-vested at September 30, 2023	—
Non-vested at January 1, 2022	14,007	28.42
Granted	4,441	33.78
Vested	(4,523)	27.35
Non-vested at September 30, 2022	13,925	30.47